Get the Stockscreener App
0.4831
3.90%
-0.0196
AEON Biopharma Inc. Stock (AEON) Forecast
The AEON Biopharma Inc. (AEON) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.4402, representing a +198.11% increase from the current price of $0.4831. The highest analyst price target is $2.8504, and the lowest is $0.03.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AEON Price Target
Average 6.6719
(+1,281% Upside)
Is AEON Biopharma Inc. (AEON) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 23.52 | Buy |
| STOCH(9,6) | 42.52 | Neutral |
| STOCHRSI(14) | 66.93 | Neutral |
| MACD(12,26) | -0.0457 | Sell |
| ADX(14) | 42.49 | Sell |
| William %R | -99.96 | Buy |
| CCI(14) | -291.27 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6724
Sell
|
0.6376
Sell
|
| MA20 |
0.6788
Sell
|
0.6761
Sell
|
| MA50 |
0.761
Sell
|
0.7581
Sell
|
| MA100 |
0.9071
Sell
|
0.84
Sell
|
| MA200 |
0.9459
Sell
|
0.8607
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, AEON could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on AEON, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23.52 indicates that AEON is oversold. This indicates that AEON price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 42.52 indicates that AEON is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.93 indicates that AEON is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 42.49 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -291.27 indicates that AEON is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term AEON price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about AEON Biopharma Inc. financial reports and earnings history, AEON Biopharma Inc. (AEON) stock could reach $2.5676 by 2030, $16.50 by 2040 and $28.07 by 2050. See the projected annual prices until 2050 of the AEON Biopharma Inc. stock below:
- AEON Biopharma Inc. (AEON) is expected to reach an average price of $13.23 in 2035, with a high prediction of $12.54 and a low estimate of $8.3762. This indicates an $2,639% rise from the last recorded price of $0.4831.
- AEON Biopharma Inc. (AEON) stock is projected to chart a bullish course in 2040, with an average price target of $14.87, representing an $2,978% surge from its current level. The forecast ranges from a conservative $15.31 to a sky-high $16.50.
- Our analysts predict AEON Biopharma Inc. (AEON) to jump 5,634% by 2045, soaring from $20.92 to an average price of $27.70, potentially reaching $28.14. While $20.92 is the low estimate, the potential upside is significant.
- AEON Biopharma Inc. (AEON) stock is expected to climb by 2050, reaching an average of $26.46, a $5,378% jump from its current level. However, a wide range of estimates exists, with high and low targets of $28.07 and $27.31, respectively, highlighting the market's uncertainty.
AEON Biopharma Inc. Stock (AEON) Year by Year Forecast
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2026
The predicted value for AEON Biopharma Inc. (AEON) in 2026 is set at an average of $7.1511. Estimates vary from a peak of $14.29 to a trough of $0.00774, indicating an +1,380% surge from the present price of $0.4831.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2026 | $0.03 | $0.03 | $2.8504 | -93.79% |
| September, 2026 | $1.5009 | $0.1602 | $2.2506 | +210.69% |
| October, 2026 | $0.2517 | $0.0815 | $1.9361 | -47.90% |
| November, 2026 | $1.2825 | $0.00774 | $1.5525 | +165.46% |
| December, 2026 | $2.9434 | $0.7458 | $4.2234 | +509.27% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for AEON Biopharma Inc. (AEON) is $6.6724, with a high forecast of $13.34 and a low forecast of $0.00868. This indicates an +1,281% increase from the last price of $0.4831.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.5542 | $2.4538 | $4.6042 | +842.69% |
| February, 2027 | $5.8749 | $2.6243 | $6.1349 | +1,116% |
| March, 2027 | $11.89 | $5.6751 | $11.98 | +2,360% |
| April, 2027 | $3.8566 | $2.5544 | $13.34 | +698.30% |
| May, 2027 | $2.037 | $0.0872 | $3.9868 | +321.65% |
| June, 2027 | $0.8109 | $0.4568 | $1.0732 | +67.86% |
| July, 2027 | $0.4181 | $0.00868 | $0.9637 | -13.45% |
| August, 2027 | $0.4072 | $0.8804 | $0.7126 | -15.72% |
| September, 2027 | $0.3915 | $0.0285 | $1.475 | -18.96% |
| October, 2027 | $2.6825 | $0.1918 | $3.1592 | +455.26% |
| November, 2027 | $3.9434 | $1.5979 | $4.8134 | +716.27% |
| December, 2027 | $6.3921 | $3.0511 | $8.8521 | +1,223% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2028
In 2028, AEON Biopharma Inc. (AEON) is projected to reach an average price of $6.1995, with a high projection of $12.38 and a low estimate of $0.0215. This indicates an +1,183% rise from the last price of $0.4831.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.683 | $1.611 | $12.38 | +662.37% |
| February, 2028 | $0.716 | $0.0215 | $3.9208 | +48.22% |
| March, 2028 | $1.4642 | $1.0783 | $1.74 | +203.07% |
| April, 2028 | $2.173 | $1.1536 | $0.863 | +349.81% |
| May, 2028 | $1.5166 | $2.0125 | $1.8372 | +213.93% |
| June, 2028 | $0.6255 | $0.7508 | $0.6513 | +29.47% |
| July, 2028 | $0.8657 | $0.3557 | $2.0951 | +79.19% |
| August, 2028 | $2.9321 | $0.5715 | $3.8021 | +506.93% |
| September, 2028 | $6.9632 | $2.0474 | $6.9879 | +1,341% |
| October, 2028 | $5.8943 | $4.7791 | $11.42 | +1,120% |
| November, 2028 | $1.6292 | $0.6676 | $3.0396 | +237.25% |
| December, 2028 | $2.1543 | $1.984 | $2.94 | +345.94% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2029
The 2029 price forecast for AEON Biopharma Inc. Stock (AEON) is $5.3199 on average, with a high prediction of $10.46 and a low estimate of $0.1792. This represents an +1,001% increase from the previous price of $0.4831.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.3202 | $2.3158 | $2.0102 | +587.27% |
| February, 2029 | $3.3889 | $3.1445 | $2.9617 | +601.48% |
| March, 2029 | $1.5675 | $1.8375 | $2.616 | +224.48% |
| April, 2029 | $0.3562 | $0.5168 | $1.4959 | -26.26% |
| May, 2029 | $0.0679 | $0.3221 | $1.5551 | -85.94% |
| June, 2029 | $4.9792 | $0.1792 | $5.9992 | +930.69% |
| July, 2029 | $4.7306 | $3.8206 | $10.46 | +879.21% |
| August, 2029 | $1.3753 | $0.2758 | $6.2734 | +184.68% |
| September, 2029 | $3.8496 | $2.6525 | $4.14 | +696.86% |
| October, 2029 | $3.4877 | $3.4781 | $2.6827 | +621.95% |
| November, 2029 | $4.8162 | $4.2766 | $4.0862 | +896.94% |
| December, 2029 | $2.7047 | $3.0747 | $3.8858 | +459.87% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2030
AEON Biopharma Inc. Stock (AEON) is expected to reach an average price of $4.7626 in 2030, with a high forecast of $9.5021 and a low forecast of $0.0232. This signifies an +885.85% surge from the last price of $0.4831.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.4128 | $1.5734 | $2.5676 | +192.45% |
| February, 2030 | $1.0013 | $0.4317 | $0.7575 | +107.27% |
| March, 2030 | $3.4302 | $0.0398 | $3.5802 | +610.04% |
| April, 2030 | $8.0217 | $3.3103 | $8.1117 | +1,560% |
| May, 2030 | $2.7664 | $0.0232 | $9.5021 | +472.64% |
| June, 2030 | $6.03 | $3.5657 | $5.34 | +1,148% |
| July, 2030 | $4.3104 | $4.6404 | $3.9121 | +792.23% |
| August, 2030 | $5.4087 | $4.6425 | $4.9766 | +1,020% |
| September, 2030 | $4.227 | $4.917 | $5.2108 | +774.97% |
| October, 2030 | $2.3774 | $4.0111 | $3.7891 | +392.10% |
| November, 2030 | $0.6157 | $1.4657 | $1.8065 | +27.44% |
| December, 2030 | $0.856 | $0.964 | $1.9534 | +77.20% |
2.64%
Cap:
|
Volume (24h):